All Pharma News
Brii Bio Presents Phase 2 Chronic Hep B Data At EASL 2024

Brii Bio Presents Phase 2 Chronic Hep B Data At EASL 2024
PR NEWSWIRE
07 Jun 2024
Share Share
Brii Biosciences Provides Corporate Update and Reports FY23 Financial Results

Brii Biosciences Provides Corporate Update and Reports FY23 Financial Results
PR NEWSWIRE
22 Mar 2024
Share Share
Brii punts HIV, depression, lung programs to potential partners

Brii punts HIV, depression, lung programs to potential partners
James Waldron FIERCE BIOTECH
22 Mar 2024
Share Share
VBI Vaccines shrinks `long-term burn` with $33M Brii Bio deal

VBI Vaccines shrinks `long-term burn` with $33M Brii Bio deal
FIERCE PHARMA
14 Feb 2024
Share Share
Brii Biosciences Announces Agreement to Acquire VBI`s IP Rights in BRII-179

Brii Biosciences Announces Agreement to Acquire VBI`s IP Rights in BRII-179
PR NEWSWIRE
13 Feb 2024
Share Share
Brii Bio Presents Data Highlighting Progress Towards Achieving HBV Cure

Brii Bio Presents Data Highlighting Progress Towards Achieving HBV Cure
PR NEWSWIRE
13 Nov 2023
Share Share
VBI Vaccines Partner Brii Announces Results of Phase 2 Study Evaluating BRII-179

VBI Vaccines Partner Brii Announces Results of Phase 2 Study Evaluating BRII-179
BUSINESSWIRE
06 Sep 2023
Share Share
Brii Biosciences Provides Corporate Updates and Reports 2023 Interim Results

Brii Biosciences Provides Corporate Updates and Reports 2023 Interim Results
PR NEWSWIRE
22 Aug 2023
Share Share
Brii pays VBI $15M for global rights to hepB program and more

Brii pays VBI $15M for global rights to hepB program and more
Nick Paul Taylor FIERCE BIOTECH
06 Jul 2023
Share Share
Brii Biosciences Provides Latest Clinical Development and Corporate Updates

Brii Biosciences Provides Latest Clinical Development and Corporate Updates
PR NEWSWIRE
05 Jul 2023
Share Share